Integra LifeSciences Holdings Corp (IART) is a leading global medical technology company focused on the development, manufacture, and marketing of surgical implants and medical instruments for use primarily by neurosurgeons, extremity-reconstruction surgeons, and general surgeons. Founded in 1989 and headquartered in Princeton, New Jersey, Integra has emerged as a renowned name in the medical devices sector, having established a significant presence worldwide.
The company operates through two main segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). CSS offers a range of products for neurosurgery, including a comprehensive line of cranial stabilization and brain retraction systems, advanced energy-based products, and dural repair products. OTT, on the other hand, caters to principally hand and wrist, ankle and foot, shoulder, and elbow solutions, as well as biologic tissue repair products.
Integra's product portfolio covers a wide range of solutions, from surgical tools to implants, and technologies used for repairing soft tissue, bone graft solutions, and many other neurosurgical applications. The company has a track-record of launching innovative new products to enhance patient outcomes, demonstrating their commitment to bringing practical solutions to the global healthcare community.
As of recent reports, the company operates in more than 50 countries and has more than 4,000 employees worldwide. The business model enables a diverse range of growth opportunities through internal product development, manufacturing, distribution, partnerships with leading surgeons and medical institutions, and a series of targeted acquisitions that broaden its product portfolio and geographic reach.
The company’s innovative solutions have made a significant impact in the field of medical technology, contributing significantly to improving patients' lives worldwide. This has positioned Integra LifeSciences as a widely-respected player within the medical technology sector.
Integra’s strong commitment to address the unmet clinical needs across its surgical portfolio qualifies them to be an integral player in the healthcare industry. Through collaborations with clinicians and investments in R&D, the company aims to provide the most technologically advanced and effective medical solutions to enhance patients’ care, thereby fulfilling its mission of limiting uncertainty for surgeons, so they can concentrate on providing the best patient care.
In the face of global healthcare challenges, Integra LifeSciences continuously seeks to invent and commercialize products that will positively affect patients' lives. From surgery to recovery, Integra's products are designed to provide surgeons with the most advanced tools and technologies that enable better surgical procedures and patient outcomes, thereby making a real difference in the field of surgery and patient care.